St. Jude Medical Announces Regulatory Approvals and Market Launch of the QuickSite XL Lead (Business Wire via Yahoo! Finance)
ST. PAUL, Minn.----May 2, 2006--St. Jude Medical, Inc. today announced U.S. Food and Drug Administration approval, receipt of European CE Mark clearance and market launch of the QuickSite XL bipolar, left-heart lead to treat heart failure patients.

Amarillo Biosciences Schedules Annual Meeting and Issues Progress Report (SYS-CON Media)
Amarillo Biosciences, Inc. (ABI) (OTC BB: AMAR), today announced its annual shareholder's meeting will be held June22, 2006 in Amarillo, Texas at the Days Inn, East 1701 E IH40 starting at10 am. The proxy material was submitted to the SEC for review last week. Atthe shareholder's meeting, the following corporate developments will bediscussed:

Pfizer tries not to be caught napping (CNN Money)
Pfizer could use a new blockbuster and the sleeping pill industry could use a new drug, and both could happen this summer if the FDA approves Indiplon at its review later this month.